Chinas Sweetener Makers Advance on WHO Aspartame Speculation - Bloomberg

300146 Stock   12.52  0.14  1.13%   
About 52% of By Health's investors are presently thinking to get in. The analysis of overall sentiment of trading By health stock suggests that some investors are interested at this time. The current market sentiment, together with By Health's historical and current headlines, can help investors time the market. In addition, many technical investors use By health stock news signals to limit their universe of possible portfolio assets.
  
Chinas Sweetener Makers Advance on WHO Aspartame Speculation Bloomberg

Read at news.google.com
Google News at Macroaxis
  

By Health Fundamental Analysis

We analyze By Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of By Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of By Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

By Health is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

By health Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with By Health stock to make a market-neutral strategy. Peer analysis of By Health could also be used in its relative valuation, which is a method of valuing By Health by comparing valuation metrics with similar companies.

Complementary Tools for 300146 Stock analysis

When running By Health's price analysis, check to measure By Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy By Health is operating at the current time. Most of By Health's value examination focuses on studying past and present price action to predict the probability of By Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move By Health's price. Additionally, you may evaluate how the addition of By Health to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities